Submits application for regulatory approval in China
After extensive testing in China and compilation of the required documentation, VibroSense has submitted an application for regulatory approval for the Company's product VibroSense Meter® II, to the Chinese authority National Medical Products Administration (NMPA).In February 2022, VibroSense signed an exclusive distributor agreement with the state-owned Chinese company Genertec Universal Medical Group (UMCARE ). The agreement includes a commitment that UMCARE will assist VibroSense with the application for regulatory approval at NMPA. An approval